These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 31799764)

  • 1. Circulating Brain-enriched MicroRNAs for detection and discrimination of idiopathic and genetic Parkinson's disease.
    Ravanidis S; Bougea A; Papagiannakis N; Maniati M; Koros C; Simitsi AM; Bozi M; Pachi I; Stamelou M; Paraskevas GP; Kapaki E; Moraitou M; Michelakakis H; Stefanis L; Doxakis E
    Mov Disord; 2020 Mar; 35(3):457-467. PubMed ID: 31799764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of differentially expressed brain-enriched microRNAs in the plasma of PD patients.
    Ravanidis S; Bougea A; Papagiannakis N; Koros C; Simitsi AM; Pachi I; Breza M; Stefanis L; Doxakis E
    Ann Clin Transl Neurol; 2020 Sep; 7(9):1594-1607. PubMed ID: 32860338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salivary microR-153 and microR-223 Levels as Potential Diagnostic Biomarkers of Idiopathic Parkinson's Disease.
    Cressatti M; Juwara L; Galindez JM; Velly AM; Nkurunziza ES; Marier S; Canie O; Gornistky M; Schipper HM
    Mov Disord; 2020 Mar; 35(3):468-477. PubMed ID: 31800144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High Throughput Sequencing Identifies MicroRNAs Mediating α-Synuclein Toxicity by Targeting Neuroactive-Ligand Receptor Interaction Pathway in Early Stage of Drosophila Parkinson's Disease Model.
    Kong Y; Liang X; Liu L; Zhang D; Wan C; Gan Z; Yuan L
    PLoS One; 2015; 10(9):e0137432. PubMed ID: 26361355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA expressing profiles in A53T mutant alpha-synuclein transgenic mice and Parkinsonian.
    Mo M; Xiao Y; Huang S; Cen L; Chen X; Zhang L; Luo Q; Li S; Yang X; Lin X; Xu P
    Oncotarget; 2017 Jan; 8(1):15-28. PubMed ID: 27965467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-free microRNAs in Parkinson's disease: potential biomarkers that provide new insights into disease pathogenesis.
    Doxakis E
    Ageing Res Rev; 2020 Mar; 58():101023. PubMed ID: 32001380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentially Expressed Circular RNAs in Peripheral Blood Mononuclear Cells of Patients with Parkinson's Disease.
    Ravanidis S; Bougea A; Karampatsi D; Papagiannakis N; Maniati M; Stefanis L; Doxakis E
    Mov Disord; 2021 May; 36(5):1170-1179. PubMed ID: 33433033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression Profiling of Blood microRNAs 885, 361, and 17 in the Patients with the Parkinson's disease: Integrating Interaction Data to Uncover the Possible Triggering Age-Related Mechanisms.
    Behbahanipour M; Peymani M; Salari M; Hashemi MS; Nasr-Esfahani MH; Ghaedi K
    Sci Rep; 2019 Sep; 9(1):13759. PubMed ID: 31551498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Convergence of miRNA expression profiling, α-synuclein interacton and GWAS in Parkinson's disease.
    Martins M; Rosa A; Guedes LC; Fonseca BV; Gotovac K; Violante S; Mestre T; Coelho M; Rosa MM; Martin ER; Vance JM; Outeiro TF; Wang L; Borovecki F; Ferreira JJ; Oliveira SA
    PLoS One; 2011; 6(10):e25443. PubMed ID: 22003392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptomics and Proteomics Approach for the Identification of Altered Blood microRNAs and Plasma Proteins in Parkinson's Disease.
    Yadav SK; Jauhari A; Singh N; Pandey A; Sarkar S; Pandey S; Garg RK; Parmar D; Yadav S
    Cell Mol Neurobiol; 2023 Oct; 43(7):3527-3553. PubMed ID: 37219663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SNCA 3'UTR genetic variants in patients with Parkinson's disease and REM sleep behavior disorder.
    Toffoli M; Dreussi E; Cecchin E; Valente M; Sanvilli N; Montico M; Gagno S; Garziera M; Polano M; Savarese M; Calandra-Buonaura G; Placidi F; Terzaghi M; Toffoli G; Gigli GL
    Neurol Sci; 2017 Jul; 38(7):1233-1240. PubMed ID: 28409245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The biomarker potential of cell-free microRNA from cerebrospinal fluid in Parkinsonian Syndromes.
    Starhof C; Hejl AM; Heegaard NHH; Carlsen AL; Burton M; Lilje B; Winge K
    Mov Disord; 2019 Feb; 34(2):246-254. PubMed ID: 30557454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of blood serum micro-RNAs associated with idiopathic and LRRK2 Parkinson's disease.
    Botta-Orfila T; Morató X; Compta Y; Lozano JJ; Falgàs N; Valldeoriola F; Pont-Sunyer C; Vilas D; Mengual L; Fernández M; Molinuevo JL; Antonell A; Martí MJ; Fernández-Santiago R; Ezquerra M
    J Neurosci Res; 2014 Aug; 92(8):1071-7. PubMed ID: 24648008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. α-Synuclein BAC transgenic mice exhibit RBD-like behaviour and hyposmia: a prodromal Parkinson's disease model.
    Taguchi T; Ikuno M; Hondo M; Parajuli LK; Taguchi K; Ueda J; Sawamura M; Okuda S; Nakanishi E; Hara J; Uemura N; Hatanaka Y; Ayaki T; Matsuzawa S; Tanaka M; El-Agnaf OMA; Koike M; Yanagisawa M; Uemura MT; Yamakado H; Takahashi R
    Brain; 2020 Jan; 143(1):249-265. PubMed ID: 31816026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analyses identify differentially expressed micrornas in Parkinson's disease.
    Schulz J; Takousis P; Wohlers I; Itua IOG; Dobricic V; Rücker G; Binder H; Middleton L; Ioannidis JPA; Perneczky R; Bertram L; Lill CM
    Ann Neurol; 2019 Jun; 85(6):835-851. PubMed ID: 30990912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A panel of four decreased serum microRNAs as a novel biomarker for early Parkinson's disease.
    Dong H; Wang C; Lu S; Yu C; Huang L; Feng W; Xu H; Chen X; Zen K; Yan Q; Liu W; Zhang C; Zhang CY
    Biomarkers; 2016; 21(2):129-37. PubMed ID: 26631297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered microRNA profiles in cerebrospinal fluid exosome in Parkinson disease and Alzheimer disease.
    Gui Y; Liu H; Zhang L; Lv W; Hu X
    Oncotarget; 2015 Nov; 6(35):37043-53. PubMed ID: 26497684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant Expression of Circulating MicroRNA Leads to the Dysregulation of Alpha-Synuclein and Other Pathogenic Genes in Parkinson's Disease.
    Cai M; Chai S; Xiong T; Wei J; Mao W; Zhu Y; Li X; Wei W; Dai X; Yang B; Liu W; Shu B; Wang M; Lu T; Cai Y; Zheng Z; Mei Z; Zhou Y; Yang J; Zhao J; Shen L; Ho JWK; Chen J; Xiong N
    Front Cell Dev Biol; 2021; 9():695007. PubMed ID: 34497805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic analysis of α-synuclein 3' untranslated region and its corresponding microRNAs in relation to Parkinson's disease compared to dementia with Lewy bodies.
    Tagliafierro L; Glenn OC; Zamora ME; Beach TG; Woltjer RL; Lutz MW; Chiba-Falek O
    Alzheimers Dement; 2017 Nov; 13(11):1237-1250. PubMed ID: 28431219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent developments in circulating biomarkers in Parkinson's disease: the potential use of miRNAs in a clinical setting.
    Teixeira Dos Santos MC; Bell R; da Costa AN
    Bioanalysis; 2016 Dec; 8(23):2497-2518. PubMed ID: 27855513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.